REDW Stanley Financial Advisors LLC Maintains Position in Colgate-Palmolive Company (CL)
REDW Stanley Financial Advisors LLC continued to hold its position in Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 3,590 shares of the company’s stock at the close of the 2nd quarter. REDW Stanley Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $266,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Alliancebernstein L.P. grew its holdings in Colgate-Palmolive by 4.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after buying an additional 77,414 shares in the last quarter. Israel Discount Bank of New York purchased a new stake in Colgate-Palmolive during the 1st quarter valued at approximately $1,349,000. Principal Financial Group Inc. grew its holdings in Colgate-Palmolive by 0.6% during the 1st quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after buying an additional 7,905 shares in the last quarter. Personal Capital Advisors Corp grew its holdings in Colgate-Palmolive by 5.8% during the 2nd quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock valued at $29,209,000 after buying an additional 21,456 shares in the last quarter. Finally, Shelton Capital Management grew its holdings in Colgate-Palmolive by 37.2% during the 1st quarter. Shelton Capital Management now owns 41,487 shares of the company’s stock valued at $3,036,000 after buying an additional 11,242 shares in the last quarter. Institutional investors own 73.10% of the company’s stock.
In other Colgate-Palmolive news, SVP John J. Huston sold 14,000 shares of the stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $71.36, for a total value of $999,040.00. Following the sale, the senior vice president now owns 88,598 shares of the company’s stock, valued at approximately $6,322,353.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Justin Skala sold 74,374 shares of the stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now directly owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. Insiders have sold a total of 217,969 shares of company stock valued at $15,693,933 over the last 90 days. 1.02% of the stock is currently owned by company insiders.
Shares of Colgate-Palmolive Company (NYSE:CL) opened at 72.72 on Friday. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The company has a market capitalization of $64.05 billion, a P/E ratio of 27.02 and a beta of 0.81. The stock’s 50 day moving average price is $71.99 and its 200 day moving average price is $73.17.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same period in the prior year, the business posted $0.70 EPS. The company’s revenue was down .5% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Monday, October 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 59.48%.
A number of equities research analysts have issued reports on CL shares. BidaskClub lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a report on Friday, June 30th. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a report on Tuesday, July 4th. Jefferies Group LLC increased their price objective on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a report on Thursday, July 6th. Finally, Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $76.31.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.